The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.14
Bid: 0.13
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.02 (15.385%)
Open: 0.14
High: 0.14
Low: 0.14
Prev. Close: 0.14
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update – Aberdeen Minerals Ltd

25 Mar 2024 12:20

RNS Number : 1856I
Gunsynd PLC
25 March 2024
 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

Investee Company Update - Aberdeen Minerals Ltd

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce a corporate update from its investee company Aberdeen Minerals Limited ("Aberdeen"), a UK based Nickel-Copper exploration company, that the company has completed a conditional equity financing round supported by a new strategic shareholder.

 

Aberdeen announced an equity financing of up to £5.5 million to invest in its mineral exploration programmes for deposits of nickel, copper and cobalt in North East Scotland. Responsibly sourced and secure supplies of these metallic raw materials used in batteries and electrification are critical to a just energy transition in Scotland and the UK.

The financing comprises:

· A conditional cornerstone investment by Central Asia Metals plc ("CAML") of £3 million at 8.5 pence per share to acquire a 28.7% shareholding in Aberdeen ("Initial Investment");

· Warrants to be granted to CAML to invest an additional £2 million at 11 pence per share, which, if exercised, would take CAML ownership to 37.8%;

· An Entitlement Offer to existing shareholders to raise up to an additional £0.5 million at 8.5 pence per share.

In addition, as part of CAML's investment, and whilst CAML's shareholding remains above 10% of Aberdeen's issued share capital, CAML will have the right to nominate a director to the board of Aberdeen. Louise Wrathall, CAML's Executive Director of Corporate Development, will join the Aberdeen board upon completion of the Initial Investment.

CAML is a UK mining company trading on the AIM market of the London Stock Exchange with a market value of over £300 million. It owns and operates the Kounrad SX-EW copper operation in central Kazakhstan and the Sasa zinc-lead mine in North Macedonia.

CAML's overall investment will fund:

· Approximately 10,000 metres of drilling in two phases at Arthrath, aimed at determining the continuity of the high-grade mineralised intersections already identified at depth;

· Should this drilling be successful, the preparation of a Mineral Resource Estimate ('MRE') and scoping level financial studies would be undertaken;

· The continuation of Aberdeen's grant-supported metallurgical testwork in association with the UK Automotive Transformation Fund, a funding programme created to support the large-scale development of a high-value end-to-end electrified automotive supply chain in the UK; and

· Soil geochemistry, ground geophysics and some exploratory drilling of district scale targets and ongoing generative work across the prospective Northeast Scotland region.

Completion of CAML's investment is subject to customary closing conditions, as well as:

· The approval of certain resolutions at a general meeting of Aberdeen's shareholders;

· The granting of clearance regarding the UK National Security and Investment Act 2021; and

· The granting of merger clearance in respect of notification requirements under the Republic of North Macedonia's Law on the Protection of Competition.

Gunsynd holds 2,000,000 ordinary shares which were purchased at a price of 7.5 pence per share for a total consideration of £150,000.

 

About Aberdeen Minerals Limited:

 

Aberdeen Minerals is a privately owned UK company focused on the exploration and development of battery metal deposits in North East Scotland. Active since 2018, the company has partnered with landowners through exclusive land access and exploration agreements over geologically prospective areas of Aberdeenshire. Demand is growing for battery metals, including those targeted by the company in North East Scotland, which are strategically important for long term, responsibly sourced and secure supplies of the raw materials critical to a just energy transition in Scotland and the UK.

More information can be found on Aberdeen's website: www.aberdeenminerals.com

 

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPUMGWUPCGPA
Date   Source Headline
6th Dec 20129:57 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20127:00 amRNSApproval of Opening Position Disclosure
5th Dec 201211:11 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 201211:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Dec 201212:19 pmRNSForm 8.3 - [Evocutis PLC]
3rd Dec 20127:00 amRNSStrategic Review
3rd Dec 20127:00 amRNSFinal Results
23rd Nov 20127:00 amRNSNotice of Results
5th Nov 20127:00 amRNSIssue of Equity
21st Sep 20127:00 amRNSTR-1 Notification of Major Interest in Shares
8th Aug 201212:24 pmRNSUpdate on commencement of dealings
1st Aug 20127:00 amRNSIssue of Equity and Grant of Share Options
21st Jun 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectorate Change
4th Apr 20127:00 amRNSDirectorate Change
22nd Mar 20127:00 amRNSInterim Results
29th Feb 20127:00 amRNSNotification of Results
27th Jan 20127:00 amRNSEvocutis validates anti-ageing LabSkinT model
24th Jan 20121:35 pmRNSResult of AGM
13th Jan 20127:00 amRNSEvocutis Opens State-of-the-art laboratory
23rd Dec 20117:00 amRNSDirector/PDMR Shareholding
15th Dec 20117:00 amRNSNotice of AGM and Report and Accounts
29th Nov 20117:00 amRNSPreliminary Results
28th Nov 20117:00 amRNSEvocutis launches antimicrobial LabSkinT model
20th Oct 20115:03 pmRNSResult of GM and Change of Name to Evocutis plc
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.